Clinical trials in Donostia / San Sebastian – page 15

206 clinical trials in Donostia / San Sebastian, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SpainEnsayosClinicos.es

Donostia / San Sebastian at a glance

206

clinical trials

Research sites2

Quick filters

206 trials in Donostia / San Sebastian

Open in trial search

Parkinson's disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of BIIB122 for Patients with Parkinson's Disease

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:N2-(3-(2-(2H-1,2,3-Triazol-2-Yl)Propan-2-Yl)-1-Cyclopropyl-1H-Pyrazol-5-Yl)-N4-Ethyl-5-(Trifluoromethyl)Pyrimidine-2,4-Diamine
Sponsor:Biogen Idec Research Limited

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Trastuzumab, Tucatinib, and Vinorelbine for Patients with Advanced HER2-Positive Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Tucatinib
Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer De Mama

Contact Research Centre

Non-small cell lung cancer+4

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Osimertinib for Patients with Stage IB-IIIA Non-Small Cell Lung Cancer After Tumor Removal

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Osimertinib
Sponsor:AstraZeneca AB

Contact Research Centre

Hormone receptor positive breast cancer+1

Not recruiting

Registered drugNo placebo

Study to Improve Tolerance of Sacituzumab Govitecan with Loperamide and Filgrastim in Patients with Advanced Triple-Negative or Luminal Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Filgrastim
Sponsor:Medica Scientia Innovation Research S.L.

Contact Research Centre

Pseudomonas infection

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of 7 vs. 14 Days of Antibiotic Treatment with Meropenem for Patients with Pseudomonas Aeruginosa Blood Infection

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Amikacin
Sponsor:Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla

Contact Research Centre

Spinal muscular atrophy

Not recruiting

Investigational

Study of Taldefgrobep Alfa for Patients with Spinal Muscular Atrophy on Stable Nusinersen and/or Risdiplam Regimen or with Onasemnogene Abeparvovec-xioi History

Investigational

Spain

Participants:0–17 years · 18–64 years
Substances:Taldefgrobep Alfa
Sponsor:Biohaven Pharmaceuticals Inc.

Contact Research Centre

Endometrial cancer stage III+1

Not recruiting

Registered drug

Study on Dostarlimab, Carboplatin, and Paclitaxel for Patients with Recurrent or Advanced Endometrial Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Dostarlimab
Sponsor:Tesaro Inc.

Contact Research Centre

Diffuse large B-cell lymphoma+2

Not recruiting

Registered drug

Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Celgene Corp.

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Anastrozole
Sponsor:Novartis Pharma AG

Contact Research Centre

Coronary artery dissection

Not recruiting

Registered drugNo placebo

Study on the Effects of Metoprolol, Prasugrel, and Carbasalate Calcium in Patients with Spontaneous Coronary Artery Dissection

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Atenolol
Sponsor:Spanish Society Of Cardiology

Contact Research Centre

Dementia Alzheimer's type+1

Not recruiting

InvestigationalNo placebo

Study of Lecanemab (BAN2401) Treatment in People with Early Alzheimer's Disease: Testing Safety and Effectiveness Over 18 Months

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Lecanemab
Sponsor:Eisai Limited

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma

Registered drug

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Donostia / San Sebastian

What the registry says about research in the country

01 Neurodegenerative Diseases

Groundbreaking research focusing on Parkinson's disease and Alzheimer's disease, including studies of novel therapeutics and disease-modifying treatments.

LRRK2-driven Parkinson's treatment evaluation
Early-stage Alzheimer's interventions
Down syndrome-associated Alzheimer's research

Multiple trials investigating innovative approaches to manage disease progression and symptoms.

02 Oncology Studies

Comprehensive research into various cancer types, with emphasis on advanced colorectal cancer and melanoma treatments.

Targeted therapies for pancreatic adenocarcinoma
Brain metastases in melanoma patients
Innovative combinations for lymphomas

Focus on personalized treatment approaches and novel drug combinations.

03 Rare Diseases

Specialized research targeting Amyotrophic Lateral Sclerosis (ALS) and other rare conditions, exploring innovative therapeutic approaches.

Combined therapy approaches for ALS
Soft tissue sarcoma treatments
Ocular Myasthenia Gravis studies

Development of targeted therapies for challenging medical conditions.

Back to Spain All countries